1
Supports appetite control
Helps reduce hunger and improve portion control in many patients as part of a structured medical program.
Weekly semaglutide injection for chronic weight management
Wegovy® Injection in Dubai
Wegovy is a prescription-based semaglutide injection that may be discussed as part of a doctor-led weight management review for eligible patients in Dubai. At MyCare, the process starts with eligibility screening, health history review, and doctor guidance before any treatment option is considered. Suitability, dosage guidance, side effects, and follow-up support should always be managed by a qualified healthcare professional.
What it is
What is Wegovy?
Wegovy® contains semaglutide, a GLP-1 receptor agonist. It is used with a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults. It may also be prescribed in certain cases to reduce the risk of major cardiovascular events in adults with established heart disease and obesity or overweight.
Prescription required. Doctor assessment is mandatory.
Wegovy® is a medical treatment, not a casual or cosmetic weight-loss product. Suitability must be assessed based on BMI, health history, medications, and clinical goals.
How it helps
A doctor-led option for long-term weight management.
2
Once-weekly routine
Designed for weekly use, which may make treatment easier to follow compared with daily options.
3
Best with clinical follow-up
Works best when combined with doctor guidance, nutrition support, lifestyle changes, and routine monitoring.
How it Works
Wegovy® helps reduce appetite and improve fullness.
Semaglutide acts on GLP-1 receptors, helping the body regulate appetite, slow gastric emptying, and support better eating control. This can help patients reduce calorie intake more consistently when paired with a proper plan.
Helps reduce frequent hunger.
Supports feeling full sooner and for longer.
May reduce cravings and improve portion control.
Works best with nutrition, movement, sleep, and behavior support.
Dose Pathway
Wegovy® is started low and increased gradually.
Dose escalation is important to improve tolerability. Patients should never self-adjust the dose without a doctor’s advice.
| Dose | Typical timing | Purpose |
|---|---|---|
| 0.25 mg once weekly | Weeks 1–4 | Starting dose to help the body adjust. |
| 0.5 mg once weekly | Weeks 5–8 | First step-up dose after the starting phase. |
| 1 mg once weekly | Weeks 9–12 | Continued escalation based on doctor guidance. |
| 1.7 mg once weekly | Weeks 13–16 | Higher escalation dose; may also be a maintenance option for some patients. |
| 2.4 mg once weekly | Week 17 onward | Recommended maintenance dose for many patients if tolerated. |
0.25 mg once weekly
Typical timing
Weeks 1–4
Purpose
Starting dose to help the body adjust.
0.5 mg once weekly
Typical timing
Weeks 5–8
Purpose
First step-up dose after the starting phase.
1 mg once weekly
Typical timing
Weeks 9–12
Purpose
Continued escalation based on doctor guidance.
1.7 mg once weekly
Typical timing
Weeks 13–16
Purpose
Higher escalation dose; may also be a maintenance option for some patients.
2.4 mg once weekly
Typical timing
Week 17 onward
Purpose
Recommended maintenance dose for many patients if tolerated.
Treatment suitability must be confirmed by a qualified doctor. Results and medication options vary by patient.
MyCare pathway
Wegovy® should be part of a complete weight-management program.
01
Doctor Assessment
Review BMI, medical history, contraindications, previous attempts, goals, and medication suitability.
02
Baseline Screening
Check key labs, metabolic status, cardiovascular risk, and other factors before treatment.
03
Prescription Plan
Confirm dosing pathway, side-effect guidance, injection education, and next steps.
04
Ongoing Monitoring
Track tolerability, appetite changes, weight trends, hydration, and treatment response.
SAFETY FIRST
Who should not use Wegovy® or needs extra caution?
Suitability must always be confirmed by a licensed healthcare professional before treatment begins.
Do not use Wegovy®️ if you have:
We review your goals, symptoms, health history, medications, and expectations.
- Personal or family history of medullary thyroid carcinoma.
- Multiple Endocrine Neoplasia syndrome type 2.
- Known serious allergy to semaglutide or any ingredient in the product.
- Current use of another semaglutide-containing product or another GLP-1 receptor agonist unless specifically instructed by a doctor.
Tell the doctor before use if you have:
We review your goals, symptoms, health history, medications, and expectations.
- History of pancreatitis, gallbladder disease, or severe stomach problems.
- Kidney problems or dehydration risk.
- Diabetic retinopathy or vision changes.
- Depression, mood changes, or suicidal thoughts.
- Pregnancy, breastfeeding, or plans to become pregnant.
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and indigestion. Seek urgent medical help for severe abdominal pain, persistent vomiting, allergic reaction symptoms, signs of dehydration, severe mood changes, neck swelling, trouble swallowing, or breathing difficulty.
FAQS
Wegovy
Frequently Asked Questions
What is Wegovy?
Wegovy is a prescription-based semaglutide injection used as part of doctor-supervised weight management for eligible patients. At MyCare in Dubai, Wegovy may be discussed only after medical screening and doctor review.
Is Wegovy available in Dubai through MyCare?
MyCare can support eligible patients in Dubai with doctor-led assessment, screening guidance, prescription support, and follow-up care for Wegovy when clinically suitable.
Who may be suitable for Wegovy treatment?
Suitability depends on your BMI, medical history, current medications, weight-related risks, and doctor assessment. Wegovy is not suitable for everyone, so screening is required before starting.
Is Wegovy the same as Mounjaro or Ozempic?
Do I need a prescription for Wegovy in Dubai?
Yes. Wegovy should only be used after medical assessment and prescription guidance. MyCare follows a doctor-led process to help assess suitability, safety, dosage guidance, and follow-up needs.
What follow-up is needed during Wegovy treatment?
Follow-up may include progress checks, side-effect review, dosage guidance, nutrition support, and health monitoring. Regular follow-up helps the doctor assess whether treatment remains suitable.
Is Wegovy Pill different from Wegovy injection?
Yes. Wegovy injection and Wegovy Pill are different treatment formats. Wegovy injection is a once-weekly injectable option, while Wegovy Pill is an oral option that may be discussed separately after doctor review. Suitability depends on your health profile, medical history, availability, and prescription guidance. Patients looking for the oral option can learn more about Wegovy Pill in Dubai before booking a doctor-led assessment.
RELATED OPTIONS
Compare Wegovy with other doctor-supervised options.
Explore other prescription-based GLP-1 and weight management options available through MyCare in Dubai. Each option is reviewed with medical screening, doctor guidance, and follow-up support when clinically suitable.
Foundayo GLP-1 Pill
Prescription required
Wegovy Pill
Prescription required
Ozempic Injection
Prescription required
Mounjaro
Prescription required
GET STARTED TODAY
We’re here to support your
health journey.
Speak to our care team to ask questions, check your eligibility, and take the first step toward a healthier you.
Your health information is safe and confidential.